Blog from IFPMA ADG Greg Perry following his visit to Cabo Verde
Find out here an insight that Greg Perry gives around WHO Afro Global Health Forum 2019
Read More
Thought Leader Series in Vaccines
A mustread from experts talking about the value of vaccines
Read More
Our response to Zika virus
Check here about the R&D blueprint against Zika
Read More
Women’s Cancer Initiative in the Americas
Partnership to improve prevention of women’s cancers and quality of cancer registries in LAC reaches 1 year milestone
Read More
Latest News
2021-06-22 15:01:46
New Non-State Actors Alliance calls on behalf of patients, industry for urgent action to set up the African Medicines Agency by the end of 2021
22 June – Paris/Geneva/London – Ministers of Health from four African countries (Algeria, Democratic Republic of Congo, Egypt and Cabo ...
Read More2021-06-22 06:37:18
Biopharmaceutical CEO Brussel meeting with EU leaders focuses on equitable access to tackle COVID-19, fostering innovation and unmet needs
Brussels, 22 June 2021 – The Biopharmaceutical CEO Roundtable (BCR), which represents the world’s leading ...
Read More2021-06-11 20:12:00
Biopharmaceutical industry welcomes COVID-19 vaccine-sharing pledges but warn challenges remain to urgently address vaccine inequity
G7 country dose sharing announcements on the back of the G20 pledges combined with vaccine ...
Read More2021-06-04 00:01:45
Government and Life Science Industry Join Forces on 100 Days Mission for Future Pandemics
Landmark collaboration between Government and life sciences industry leaders to join mission to protect against ...
Read More2021-05-24 11:33:27
Global biopharmaceutical industry sees upcoming World Health Assembly as a critical milestone to take stock of progress achieved and discuss enablers for future pandemic preparedness
24 May 2021, Geneva – The 74th World Health Assembly, taking place in extraordinary circumstances, ...
Read More2021-05-19 05:30:03
Five steps to urgently advance COVID-19 vaccine equity
19 May 2021 07h00 CET– Innovative vaccine manufacturers and biotech companies are at the forefront ...
Read More2021-04-23 14:00:15
ACT-Accelerator 1-Year Anniversary: the biopharmaceutical industry is committed to continue to play a critical role across ACT-A and accelerate equitable and fair access to COVID-19 tools
Geneva, 23 April 2021 – Today we welcome the one-year Anniversary of ACT Accelerator (ACT-A) ...
Read More
Latest Statement
2021-07-21 18:59:26
IFPMA Statement at WTO-WHO High Level Dialogue “Expanding COVID-19 Vaccine Manufacture to Promote Equitable Access” – Session title: Looking ahead
21 July 2021 – Today, as stated by Dr Ngozi Okonjo-Iweala, Director General of the World Trade Organization, we are ...
Read More2021-07-15 08:52:02
COVAX launches Marketplace to match buyers and sellers of critical manufacturing suppliers and speed up global access to COVID-19 vaccines through COVAX
Geneva, 23 April 2021 – Today we welcome the one-year ...
Read More2021-07-06 09:10:26
Global regulators and coalition of pharma and vaccine manufacturing associations come together to discuss COVID-19 pandemic response
Geneva, 23 April 2021 – Today we welcome the one-year ...
Read More2021-06-21 06:18:58
Statement Delivered at the 23rd WHO Expert Committee Meeting on the Selection and Use of Essential Medicines
Geneva, 23 April 2021 – Today we welcome the one-year ...
Read More2021-06-12 16:47:01
Innovative biopharmaceutical industry welcomes the G7 agreement to work in partnership with the private sector towards a 100 Days Mission to improve readiness for future pandemics
Geneva, 23 April 2021 – Today we welcome the one-year ...
Read More2021-06-10 20:00:47
IFPMA and local pharmaceutical industry associations call on the African and global health communities to raise awareness about the dangers of substandard and falsified medical products
Geneva, 23 April 2021 – Today we welcome the one-year ...
Read More2021-06-10 16:06:40
R&D bio-pharmaceutical groups warn about rise in COVID-19 falsified medical products in Africa and call governments to ratify the Medicrime Convention to crack down on illicit activities
Geneva, 23 April 2021 – Today we welcome the one-year ...
Read More
mailto:a.jones@ifpma.org
Abigail Jones - Director, Communications
Abigail Jones is responsible for communications at IFPMA. She joined IFPMA after over 25 years in international communications and public affairs consultancy, where she worked for many blue-chip companies, trade associations, think tanks, coalition and advocacy groups. Abigail supported the launches and ongoing work of the Fight the Fakes campaign, AMR Industry Alliance and Pat-INFORMED.
mailto:m.depol@ifpma.org
Twitter @MorganePol
Morgane De Pol - Deputy Director, Communications
Morgane develops and implements public affairs programs that build trust, dialogue and collaboration between the innovative biopharmaceutical industry and other global players in the health community. Morgane has international experience in developing and rolling-out integrated advocacy and communications strategies in the global health sector, with specific focus on institutional communications, media relations, alliance building and event management.
Our Brouchure
2015 Edition
A shared commitment to global health
At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.
Our Logo
Full colour EPS format
Our Logo
Full colour PNG format
FULL Name LOGO
Full colour EPS format
FULL Name LOGO
Full colour PNG format
News Release
Meeting discusses COVID-19 vaccine manufacturing bottlenecks that must be urgently tackled for C19 vaccine output to reach its full potential
9 March 2021: Chatham House, in collaboration with COVAX, IFPMA, DVCMN, and BIO, convened a Global COVID-19 Vaccine Supply Chain & Manufacturing Summit on 8th and 9th March. The unprecedented scaling up of vaccine manufacturing, from zero to billions of
Read MoreOur Blog
Enabling the next generation of African Health Leaders for the road ahead
At this year’s regional World Health Summit in Uganda, we had the pleasure of showcasing the research fellows that IFPMA has been supporting as part of the Chatham House African Public Health Leaders fellowship program since 2016 in an event titled “Will COVID-19 dictate a new paradigm in Africa?” This event was a unique opportunity to get a 'temperature check' from public health leaders on...
Read More
Each and every country faces unique challenges in rolling out COVID-19 vaccination (Step #4)
We have a realistic hope of producing 11 billion COVID-19 vaccines by the end of 2021 to vaccinate the world’s whole adult population. With increased dose sharing and urgent measures to ensure vaccine equity through COVAX and other bilateral agreements, we would like to see many more vaccines reaching all four corners of the world in the second half of 2021. So that every dose...
Read More
Why we must remove barriers to trade to achieve vaccine equity (Step #3)
To put an end to the pandemic, industry was tasked with manufacturing and supplying billions of COVID-19 vaccines, starting from zero. This monumental task is on its way to being achieved, with 11 billion doses forecast for the end of 2021[1]—enough for the world’s adult population, according to the World Bank. However, trade restrictions, amongst other hurdles, are holding up both upstream and downstream supply,...
Read MoreLatest Tweets
